Neures s.r.o.
- Address
- Snp 25, 053 42 Krompachy, Slovakia
Neures s.r.o. - Neurodegenerative and Neurological Disorders Research Center
Neures s.r.o. is a specialized clinical research center with extensive expertise in neurodegenerative diseases and neurological conditions. The center demonstrates particular strength in conducting complex trials for Alzheimer's disease and its associated complications, as well as comprehensive migraine prevention studies. Their research portfolio reflects a commitment to advancing therapeutic options for patients suffering from cognitive decline and debilitating neurological symptoms.
- Alzheimer's disease spectrum disorders including early-stage disease, mild cognitive impairment, and associated behavioral symptoms (psychosis and agitation)
- Migraine prevention therapies for both episodic and chronic migraine presentations
- Cognitive function preservation and dementia management with novel therapeutic approaches
- Neuropsychiatric symptom management in neurodegenerative conditions
The center's research capabilities span from evaluating disease-modifying treatments for cognitive impairment to symptom-specific interventions targeting behavioral disturbances in dementia. With experience in both oral pharmaceutical agents and injectable biologics, Neures s.r.o. employs validated assessment tools such as the CDR-SB score, BEHAVE-AD scale, and CMAI to measure treatment efficacy across diverse neurological conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Intra-Cellular Therapies Inc.2active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Intra-Cellular Therapies Inc.2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Neures s.r.o.
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Clostridium Botulinum Neurotoxin Type A in Chronic Migraine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial | Merz Therapeutics GmbH | Phase III | Recruiting | Oct 2025 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins | 2 | Unknown | 2025-10-06 | 2025-10-06 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.